Re-Intervention in the in the RVOT: From conduits to native outflow tracts

Presentation by: John Cheatham, MD, FSCAI

Nationwide Children’s Hospital, Columbus, Ohio

cheatham john  Portrait Best Edited 5-08John P. Cheatham, MD, is Director of Cardiac Catheterization and Interventional Therapy and Co-Director of The Heart Center at Nationwide Children’s Hospital, Columbus, Ohio. He holds the George H. Dunlap Endowed Chair in Interventional Cardiology. He is also a Professor of Pediatrics and Internal Medicine at The Ohio State University College of Medicine. After graduating from the University of Oklahoma College of Medicine, he completed his residency at Boston Children’s Hospital, followed by a fellowship in Pediatric Cardiology at Texas Children’s Hospital in Houston. Dr. Cheatham’s area of expertise is transcatheter intervention and Hybrid therapy of newborns, children, and adults with complex congenital heart disease. He has pioneered several new techniques and devices in nonsurgical intervention, as well as being a world leader in developing new Hybrid therapies. Dr. Cheatham has been a principal investigator in numerous FDA sponsored clinical trials evaluating nonsurgical closure devices and stent therapy over the past two decades. Additionally, Dr. Cheatham designed the world’s first Hybrid Cardiac Catheterization Suites and advanced imaging equipment at Nationwide Children’s Hospital, which allows the interventionalist & cardiothoracic surgeon to perform combined therapy in order to improve clinical outcomes in patients referred to The Heart Center. He serves as a consultant to various medical companies and proctors, or teaches, new transcatheter techniques and devices to other physicians around the world. Dr. Cheatham is Co-Director of the Nationwide Children’s Hospital International Program and has implemented a formal physician exchange program with two of the leading medical institutions in China.  In cooperation with China Red Cross, he is also the Foreign Director of the International Training Center for treatment of congenital heart disease in poor children.  Dr. Cheatham has authored more than 170 manuscripts, 20 book chapters, over 440 national and international presentations, and is co-editor of the book, “Complications in Percutaneous Interventions for Congenital and Structural Heart Disease.”  Dr. Cheatham was selected as one of the top 25 Innovators in Healthcare by Health Imaging & IT. In addition, he was honored as the recipient of the Career Achievement Award at the prestigious 2007 PICS & AICS conference, attended by interventional cardiologists from all over the world.

( average: 5.00 )
Loading...Loading...

Current status of transcatheter aortic valve implantations: Are we ready for the congenital patient?

Presented by: Helmut Baumgartner, MD

University of Muenster, Muenster, Germany

Helmut baumgartnerDr. Helmut Baumgartner is Professor of Cardiology/Adult Congenital Heart Disease at the Universiy of Muenster and Director of the Division of Adult Congenital and Valvular Heart Disease at the University Hospital Muenster in Muenster Germany. He trained in Austria, spent one year in the U.S. and was associate Professor of Medicine/Cardiology at the University of Vienna for 14 years before his appointment at the University of Muenster in 2007. Already in Austria he developed Adult Congenital Heart Disease and Valvular Heart Disease Programs at the Vienna General Hospital. He was one of the founding members of the Working Group on Adult Congenital Heart Disease of Austrian Society of Cardiology. He has served for many years as a member of the Working Group on Grown-up Congenital Heart Disease (GUCH) of the European Society of Cardiology (ESC) including chairmanship and lead the task force for the ESC Guidelines on the management of grown-up congenital heart disease.

( average: 5.00 )
Loading...Loading...
( average: 5.00 )
Loading...Loading...